Navigation Links
CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal

than historical facts) as defined in the Private Securities Litigation Reform Act of 1995 and in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward looking statements. Examples of such risks and uncertainties include, but are not limited to, RXi's need to raise significant capital to fund operations and development of its potential products, the need to establish management and other infrastructure for the RXi subsidiary, intense competition with other companies focused on RNAi and other larger companies with RNAi programs and with other existing or new therapeutic modalities, the early stage of development of RXi's technology, and the scope, timing and outcome of pre-clinical and clinical testing and regulatory review of RXi's potential products. Additional risks or uncertainties are described in CytRx's most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. All forward-looking statements are based upon information available to CytRx on the date the statements are first published. CytRx undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

Contact

CytRx Corporation
CEOcast, Inc.
Dan Schustack, 212-732-4300
dschustack@ceocast.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
(Date:8/28/2015)... 2015 Research and ... the "Investigation Report on China,s Insulin Aspart ... Developed by Novo Nordisk, insulin aspart (under ... drug for the treatment of diabetes. Compared with ... insulin analog, starts working fast and reports higher ...
(Date:8/28/2015)...  IP Shakti, LLC, today announced that it has changed ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... identity signifies our transformation into a company focused on patent ... patent claim validity." ... Shield™ platform, the Company commenced a corporate re-branding initiative in ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... Sept. 1, 2011 diaDexus, Inc. (OTC Bulletin Board: ... commercialization of patent-protected in vitro diagnostic products ... it plans to present at Baird,s 2011 Health Care ... Eastern Time (6:30 am Pacific Time) at the New ...
... Sept. 1, 2011 Cardium Therapeutics (NYSE Amex: ... Chief Executive Officer, will present at the Rodman & Renshaw ... 2:25 p.m. Eastern Time.  The conference is being held September ... webcast of the Company,s presentation will be available live and ...
Cached Medicine Technology:Cardium to Present at the Rodman & Renshaw Annual Healthcare Investment Conference 2
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik ... zero standard shipping costs. , “Before, a threshold of $49.00 was required to qualify ... and items qualify for free standard shipping for customers regardless of the item’s selling ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, ... ... consistently successful results and include treating the localized area with stretching, soft tissue ... and a neutral pelvic position have shown through research to improve treatment ...
(Date:8/29/2015)... ... 2015 , ... Vascular Health Sciences announced today that an ... HP, and that all claims and counterclaims have been irrevocably dismissed. , In ... the United States District Court for the Southern District of Texas for breach ...
(Date:8/28/2015)... Sierra Madre, CA (PRWEB) , ... August 28, ... ... alternative solutions to wound center management, Decatur County Memorial Hospital recently transitioned management ... model of Wound Center Management for their outpatient wound center. , ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... , THURSDAY, June 4 (HealthDay News) -- Ever wonder ... scab after a cut? Researchers have now pinpointed the ... body has an incredible ability to heal from life,s ... principal investigator at the Rowland Institute at Harvard University, ...
... , Remuda Ranch ( www.remudaranch.com ) Reports Many Patients with ... , PHOENIX, June 4 /PRNewswire/ -- ... with eating disorders repeatedly check their body and often in ... http://www.newscom.com/cgi-bin/prnh/20090604/CG27861LOGO ) , , "Sometimes body and weight checking ...
... New York,s Rainbow Room on May 27th ... Damon Runyon Cancer Research Foundation . The Foundation ... funded through competitive and prestigious award programs, targeting all types of ... by Joe Kernen, co-anchor of CNBC ,s flagship ...
... eighth graders present seat belt safety messages for a chance to ... Nickelodeon or area billboards. , , CLEVELAND, June ... the Plaza Lobby stage at the Rock and Roll Hall ... June 6 , to perform songs, screen videos, and present posters ...
... June 04, 2009 - Patients with heart attacks and ... times more likely to experience serious complications after hospital ... department (ED), according to a new study published in ... say that this dramatic difference in rates of serious ...
... in image and information management solutions highlights Enterprise Content ... , , BOSTON, June 4 AMICAS, ... image and information management solutions, today announced that it ... a vendor-neutral archive solution designed to lower the total ...
Cached Medicine News:Health News:Researchers Detect Blood-Clotting Mechanism 2Health News:Body and Weight Checking May Signify an Eating Disorder 2Health News:Body and Weight Checking May Signify an Eating Disorder 3Health News:NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck 2Health News:NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck 3Health News:Finalists Perform at Rock Hall in Rainbow Babies & Children's Hospital's 'Pause to Click' Contest Encouraging Safety Belt Use for Tweens 2Health News:Crowded emergency departments pose greater risks for patients with heart attacks 2Health News:Crowded emergency departments pose greater risks for patients with heart attacks 3Health News:AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009 2Health News:AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009 3Health News:AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009 4
... 3D Signature is a state of ... that integrates blood, sterile body fluid ... powerful microbiology workstation with comprehensive capabilities. ... identification and where expanded flexibility in ...
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid SS/u, a microbial identification system....
Medicine Products: